Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL

Publisher:
Rockefeller University Press
Publication Type:
Journal Article
Citation:
Journal Of Experimental Medicine, 1999, 189 (8), pp. 1343 - 1353
Issue Date:
1999-01
Full metadata record
Files in This Item:
Filename Description Size
Thumbnail2011003804OK.pdf165.7 kB
Adobe PDF
TRAIL (tumor necrosis factor [TNF]-related apoptosis-inducing Ligand) is a molecule that displays potent antitumor activity against selected targets. The results presented here demonstrate that human monocytes rapidly express TRAIL, but not Fas ligand or TNF, after activation with interferon (IFN)-gamma or -alpha and acquire the ability to kill tumor cells. Monocyte-mediated tumor cell apoptosis was TRAIL specific, as it could be inhibited with soluble TRAIL receptor. Moreover, IFN stimulation caused a concomitant loss of TRAIL receptor 2 expression, which coincides with monocyte acquisition of resistance to TRAIL-mediated apoptosis. These results define a novel mechanism of monocyte-induced cell cytotoxicity that requires TRAIL, and suggest that TRAIL is a key effector molecule in antitumor activity in vivo.
Please use this identifier to cite or link to this item: